Status:
COMPLETED
Association of Circulating ACE2 Levels With COVID-19
Lead Sponsor:
Jordan University Hospital
Conditions:
COVID-19
COVID-19 Respiratory Infection
Eligibility:
All Genders
18+ years
Brief Summary
COVID-19 cases are rising substantially in Jordan. Since this is a novel virus, there is still much to be investigated surrounding its pathophysiology in order to attempt to find suitable treatments o...
Detailed Description
SARS-CoV-2 is a new isolate of coronavirus that caused an epidemic in Wuhan, China in December 2019. The virus has then spread to the rest of the world causing a pandemic, and the disease the virus ca...
Eligibility Criteria
Inclusion
- Age: 18 and above
- Gender: both males and females.
- Confirmed diagnosis of COVID-19 for patients and confirmed absence of COVID-19
Exclusion
- Healthy individuals: not being diagnosed with COVID-19 or at least has not been in close contact with a person diagnosed with COVID-19.
Key Trial Info
Start Date :
January 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 21 2022
Estimated Enrollment :
261 Patients enrolled
Trial Details
Trial ID
NCT05205707
Start Date
January 1 2022
End Date
January 21 2022
Last Update
February 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Jordan
Amman, Jordan, 11972